AI ML expansion AHRM has publicly launched artificial intelligence and machine learning services, indicating openness to advanced analytics partnerships that can enhance health economics, outcomes research, and real-world evidence capabilities for clients.

Global CRO focus As a full service global CRO with North America and Europe coverage and experience across major therapeutic categories, AHRM presents opportunities for cross-border studies, regulatory submissions support, and multinational payer research collaborations.

Small scale agility With a lean team of 2-10 employees, there is potential to position AHRM for high-value, personalized engagements, fast onboarding, and scalable collaborations where larger vendors may struggle with flexibility.

Economic health Current revenue range of one to ten million USD suggests opportunities for expanded project scopes, longer-term contracts, and upsell of health economics outcomes research services to existing or prospective pharmaceutical and medical device clients.

Strategic partnerships Comparable market players include large CROs; AHRM can differentiate by offering targeted health economics analytics, real world evidence, and AI-enabled insights to attract mid-market sponsors seeking specialized expertise.